People: Solazyme Inc (SZYM.O)

SZYM.O on Nasdaq

2.76USD
21 Nov 2014
Price Change (% chg)

$-0.15 (-5.15%)
Prev Close
$2.91
Open
$3.00
Day's High
$3.01
Day's Low
$2.67
Volume
3,360,930
Avg. Vol
1,860,148
52-wk High
$15.00
52-wk Low
$2.67

Search Stocks

Licari, Peter 

Brief Biography

Dr. Peter J. Licari, Ph.D., is Chief Technology Officer of Solazyme Inc.From 2010 to 2012, he served as our Executive Vice President, Research and Development. He served as our Senior Vice President, Research and Development from 2008 until 2010. From 1998 to 2008, Dr. Licari held various positions at Kosan Biosciences, Inc., a biopharmaceutical company. In his last position at Kosan Biosciences, Inc. he served as Senior Vice President, Manufacturing and Operations responsible for the process development and manufacturing of Kosan’s clinical compounds. From 1993 to 1996, Dr. Licari served as the Director of Vaccine Manufacturing and Development at Massachusetts Biologic Laboratories, a part of the University of Massachusetts, an academic institution. Prior to joining Massachusetts Biologic Laboratories, Dr. Licari had a variety of research positions at BASF Bioresearch Corporation, a biopharmaceutical company, and Merck & Co., Inc., a pharmaceutical company. Dr. Licari obtained his Ph.D. in Chemical Engineering from the California Institute of Technology and obtained a M.B.A. from Pepperdine University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
506,784 -- 249,795 1,925,580

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 66,000 587,578.00
Name Fiscal Year Total

Jerry Fiddler

--

Jonathan Wolfson

3,477,950

Tyler Painter

1,926,360

Peter Licari

1,925,580

Paul Quinlan

1,229,730

James Craigie

--
As Of 30 Dec 2013
Search Stocks